Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the Lung

Molecular therapies targeting epidermal growth factor receptor (EGFR) have had a profound impact on the management of advanced non-small cell lung cancer (NSCLC). EGFR inhibition with EGFR tyrosine kinase inhibitors (EGFR-TKIs) and anti-EGFR monoclonal antibodies (mAbs) in squamous NSCLC (sqNSCLC) r...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Goss, Glenwood D., Spaans, Johanna N.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2016
Sujets:
Lung Cancer
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746081/
https://ncbi.nlm.nih.gov/pubmed/26768483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0209
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires